NCT02419079: DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
|
|
| Not yet recruiting | 1/2 | 116 | US | DNA Plasmid Encoding Interleukin-12 INO-9012, INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Placebo, placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment | National Cancer Institute (NCI) | Chronic Hepatitis, Hepatitis C Infection | 10/17 | | | |
